The revenue stands at ₹1,421.64 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.40 per cent from ₹1,374.84 crore. This corresponds to a year-on-year *(YoY) growth of 21.47 per cent.
Operating Profit stands at ₹333.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.77 per cent from ₹382.24 crore. This corresponds to a year-on-year *(YoY) growth of 12.20 per cent.
PBDT stands at ₹392.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.39 per cent from ₹402.11 crore. This corresponds to a year-on-year *(YoY) growth of 26.94 per cent.
Profit Before Tax stands at ₹347.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.20 per cent from ₹358.60 crore. This corresponds to a year-on-year *(YoY) growth of 28.84 per cent.
Net Profit stands at ₹266.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.58 per cent from ₹273.77 crore. This represents a 18.40 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | 2.57% | 1.37% | 9.72% | 20.26% | 23.31% | 30.25% |
| Abbott India | 1.44% | 3.50% | 1.04% | 3.82% | -5.84% | -22.70% |
| Ipca Labs. | 1.12% | -0.24% | 8.71% | 22.01% | 16.25% | 23.16% |
| Anthem Bioscienc | 1.81% | -0.97% | -0.46% | 2.34% | 23.42% | 4.37% |
| Glaxosmi. Pharma | 1.96% | 2.69% | 13.00% | 2.67% | 2.43% | -24.40% |
| Gland Pharma | -0.05% | 1.26% | 9.85% | 43.20% | 46.28% | 35.22% |
| J B Chemicals & | 0.82% | 4.14% | 11.68% | 22.82% | 31.15% | 52.62% |
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah